Exclusive look at our Italian contribution to The Life Sciences Law Review

The fourth edition of The Life Sciences Review was recently published which included valued contributions made by our IP and Life Sciences group in Italy.

Our chapter provides an overview of legal issues of interest to pharmaceutical, biotechnology and medical device companies in the Italian market. It contains information on legal requirements relating to the key stages in the life cycle of a regulated product, from discovery, through the clinical development process, registration, manufacturing and promotion, plus other issues of special interest, such as pricing and reimbursement, special liability regimes, competition and commercial transactions in the context of the medical products business.

The resulting work product will assist industry lawyers, regulatory affairs staff and others who need to have an understanding of the issues in each major market.

Please click here for the PDF version of the exclusive Italy chapter. If you would like to view the eBook or PDF version of the entire Life Sciences Law Review, please click on the image.

News & Deals

More News & Deals

Deal

Bird & Bird advised Hitachi Energy in Finland on €170 million development project regarding new production and technology campus

May 02 2024

Read More

News

Bird & Bird appoints 13 to Partner, 3 to Senior Counsel, 24 to Counsel, 1 to Legal Director and 1 to Of Counsel in annual global promotion round

May 01 2024

Read More

Deal

Bird & Bird advises BRIDOR on its acquisition of the PANDRIKS Group

Apr 30 2024

Read More

News

Bird & Bird France wins Ishka: Aviation Finance Best Supported Financing Deal of the Year Award 2023

Apr 29 2024

Read More

Deal

Bird & Bird advised Sponosa Group Oy on its acquisition of Airfil Oy

Apr 26 2024

Read More

Deal

Bird & Bird advised 88 Energy on an oversubscribed placing to raise A$9.9m (£5.2m)

Apr 25 2024

Read More

Related capabilities